Professor Matt Cooper, FRSM

NHMRC Principal Research Fellow
Professor, Institute of Molecular Bioscience
Professor, School of Chemistry & Molecular Bioscience

image description

Professor Matthew Cooper is CEO of Inflazome Ltd. and has an equity interest in the company of which UQ is also a shareholder through its commercialisation company UniQuest Pty. Ltd. Inflazome Ltd. is a company headquartered in Dublin, Ireland that is developing drugs to address clinical unmet needs in inflammatory disease by targeting the inflammasome. Professor Cooper also holds a fractional Professorial Research Fellow appointment at the University of Queensland. The terms of this arrangement have been reviewed and approved by the University of Queensland, in accordance with its conflict of interest policies.

Matt Cooper completed his PhD in Australia in 1995 and then spent 13 years in the UK, first at the University of Cambridge, then in start-ups and biotechnology companies. This involved innovation, fund raising, intellectual property generation, licensing, product development and commercialisation.

He returned to Australia in 2009 as a NHMRC Australia Fellow and is now a NHMRC Principal Research Fellow. He has consulted with Private Equity Investment, Pharmaceutical, Biotechnology and Diagnostics companies, was Managing Director of Cambridge Medical Innovations (part of Alere Inc.) and CSO of Akubio Ltd. He is an inventor and driver of a several antibiotic drug discovery programmes with lead compounds pre-clinical. He is an expert in label-free technologies and their application to drug discovery and development with two books in this field.


Academic Qualifications

1992-1994 Ph.D in Organic Chemistry, University of Adelaide, Australia.

1986-1989 B.Sc and Honours Degree (1st Class), University of Adelaide, Australia.


Prizes and Awards

2016 Adjunct Professor, School of Biochemistry and Immunology, Trinity College Dublin

2014 NHMRC Principal Research Fellow

2014 Medal for Excellence, Journal of Antibiotics

2013 NHMRC Nationally Top Ranked Development Grant Award (2013)

2013 Australian Society for Antimicrobials - Howard Florey Oration

2008 NHMRC Australia Fellow.

2007 Institution of Engineering and Technology Award for Emerging Technologies.

2006 Dept. Trade & Industry Micro and Nanotechnology Innovation Award, UK.

2005 Entrepreneur of the Year Finalist, UK.

2003 Trinity College Cambridge Support Scheme Award, UK.

2002 Dept. Trade & Industry Smart Innovation Award, UK.

1999 Howard Florey Centenary Research Fellowship.

1995 George Murray Fellowship at the University of Cambridge, UK.


Professional Affiliations

Pfizer Australia Stakeholder Faculty

Fellow of the Queensland Academy of Arts and Sciences

Fellow of the Royal Society of Medicine

Member of the Royal Australian Society of Chemistry

Australian Society for Infectious Diseases

Australian Society for Antimicrobials

top of page


Invited Conference Presentations

Gordon Research Conference on Multidrug Efflux Systems, Galveston, Texas, 26-31 March, 2017

Grand Challenges Annual Meeting 2016, London, England, 23 - 26 October 2016

ESCMID-ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, Vienna, Austria, 21 – 23 September 2016

BIO 2016, San Francisco, USA, 6-10 June 2016 (2 presentations)

Elected Vice Chair of the GRC New Antibacterial Discovery & Development Conference

GRC New Antibacterial Discover & Development Conference, Tuscany, Italy, 13–18 March 2016

International Chemical Congress of the Pacific Basin Societies (Pacifichem), Honolulu, Hawaii,
15–20 December 2015

Centre for Biodiscovery Symposium – Invited Plenary Lecture, Wellington, New Zealand,
24–25 November 2015

2nd International Conference on Polymyxins, San Diego, USA, 22-24 September 2015

MedChem2015 Conference, Novosibirsk, Russia, 2015

GRC Antimicrobial Peptides, Italy, 2015

ECCMID - European Society of Clinical Microbiology & Infectious Diseases, Copenhagen, 2015

111th International Titisee conference “Rediscovering Warbug –the role of metabolism in signalling disease”, Titisee, Black Forest, Germany 2015

ICAAC - Interscience Conference on Antimicrobial Agents & Chemotherapy, Washington, USA, 2014

24th World Congress on Biosensors, Melbourne, Australia, 2014

ECCMID - European Society of Clinical Microbiology & Infectious Diseases, Barcelona, Spain, 2014

5th FIP Pharmaceutical Science World Conference, Melbourne, Australia, 2014

GRC New Antibacterials Discovery & Development, Ventura, USA, 2014

10th Australian Peptide Conference, Penang, Malaysia, 2013

ASID Gram Negative 'Superbugs' meeting, Gold Coast, Australia, 2013

ASM Conference, Adelaide, Australia, 2013

Bioeconomy China China 2013

2013 International NanoMedicine Conference, Sydney, Australia, 2013

AusMedTech conference, Melbourne, Australia, 2013

Plenary speaker presenting the inaugural "Howard Florey Oration", ASA Antimicrobials 2013, Sydney, Australia, 2013

1st International Conference on BioNano Innovation, Brisbane, Australia, 2012

Label-free Symposium, Brisbane, Australia, 2012

Plenary speaker at the International Conference on Biotechnology, Bogor, Indonesia, 2012

CASB IMB Industry Symposium, Brisbane, Australia, 2012

UQ Senior Executive Mission to Indonesia, Jakarta, Indonesia, 2012

Gordon Research Conference: New Antibacterial Discovery & Development, Italy, 2012

Australian Society for Infectious Diseases Annual Scientific Meeting, Fremantle, Australia, 2012

RACI Annual Dinner and AGM, Brisbane, Australia 2012

Emerging Infectious Diseases and bioinformatics Symposium, Singapore, 2012

Lorne Infection & Immunity, Melbourne, Australia, 2012

Screening Asia Conference, Singapore, 2011

CASB IMB Industry Symposium & Anti-Infectives Satellite Meeting, Brisbane, Australia, 2011

International Tuberculosis Research Centre, Masan, Korea, 2011

9th International Symposium on Multi Drug-Resistant Tuberculosis, Osong, Korea, 2011

Gordon Research Conference – Tuberculosis Drug Development, Barga, Italy, 2011

Eskitis Institute, Griffith University, Brisbane, Australia, 2011

Monash University, School of Chemistry, Melbourne, Australia, 2011

Monash University, Monash Institute of Pharmaceutical Science, Melbourne Australia, 2011

British Society Antimicrobial Chemotherapy Spring Meeting, London, UK, 2011

CASB IMB Industry Symposium, Brisbane, Australia, 2010

Developments in Protein Interaction Analysis, Barcelona, Spain, 2010

Australian Institute for Bioengineering & Nanotechnology Symposium, Brisbane, Australia, 2010

Royal Australian Society of Chemistry National Conference, Melbourne, Australia, 2010

Queensland Washington Global Health Symposium, Seattle, USA, 2010

LCN UCL Cantilever Workshop, Zermatt, Switzerland, 2010

Australian Toll-like Receptors, Gold Coast, Australia, 2009

8th Australian Peptide Conference, Couran Cove, Australia, 2009

University of Queensland Research Week Public Lecture, Brisbane, Australia, 2009

Sensor and Test, Nuremburg, Germany, 2009

American Association of Pharmaceutical Scientists National Conference, Seattle, USA, 2009

Advances in Biosensors for Point of Care Applications, London, UK, 2009

BioAnalytical Method Development, San Francisco, USA, 2008

Gordon Research Conference on Bioanalytical Sensor, Smithfield, USA, 2008

Plenary Speaker Nanomechanical Sensors for Biological Applications, Copenhagen, Denmark, 2008

Co-Chair, Society for Biomolecular Science European Symposium, Dresden, 2008

Biosecurity Sensors & Instrumentation, London, UK, 2007

ERBI’s 9th Annual Cambridge BioPartnering Exchange, Cambridge, UK, 2007

10th MipTech Conference, Basel, Switzerland, 2007

Gordon Research Conference on Chemical Sensors & Interfacial Design, Newport, USA, 2007

2nd IET Seminar on Micro/Nanotechnology in Medicine, London, UK, 2006

12th Annual Society for Biomolecular Science, Seattle, USA, 2006

ScreenTech World Summit, San Diego, USA, 2006

IEE Micro and Nanotechnology in Medicine, London, UK, 2006

LabAutomation, Palm Springs, USA, 2006

Biosensing technologies for medical and homeland security applications, London, UK, 2006

Measurement and Characterisation of Medical Biosensors, London, UK, 2005

AACC Oak Ridge: Pushing the Technology Envelope II, Baltimore, USA, 2005

Separation, Purification and Analysis in Drug Discovery, Göteborg, Sweden, 2004

ScreenTech World Summit, San Diego, USA, 2004

9th Annual Society for Biomolecular Screening Conference, Portland, USA, 2003

Gordon Research Conference on Chemical Sensors & Interfacial Design, Newport, USA, 2003

15th International Affinity Interactions Conference, Cambridge, UK, 2003

Nanotech Biotech Convergence, Stamford, USA, 2003

IEEE Sensors 2002, Orlando, USA, 2002

World BIAsympoisum, Chicago, USA, 2002

8th Annual Society for Biomolecular Screening Conference, Baltimore, USA, 2001

3rd Australian BIAsymposium, Brisbane, Australia, 2000

4th 2D gel electrophoresis meeting, Siena, Italy, 2000

18th International Congress of Biochemistry and Molecular Biology, Birmingham, UK, 2000

International Workshop on Biosensors Utilizing Lipid Bilayer Membranes, Mainz, Germany, 1999

US/European BIAsymposium, Edinburgh, Scotland, 1998

Reversible Associations in Structural and Molecular Biology, Melbourne, Australia, 1998

Weak Affinity Interactions Symposium, Stevenage, UK, 1997

European BIAsymposium, Montpellier, France, 1996

US BIAsymposium, Washington, USA, 1996

IBC Drug Discovery Technology Symposium, Boston, USA, 1996

RACI 10th National Conference, University of Wollongong, Australia, 1994

Organic Chemistry Symposium, Victor Harbour, Australia, 1993

RACI, 9th National Conference, Monash University, Melbourne, Australia, 1992

top of page